Combination Urothelial Cancer Treatment Nearly Doubles Patient Survival in International Trial
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Combining the anticancer drugs enfortumab vedotin and pembrolizumab led to significantly improved survival rates among pat…











































